Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

Polycystic ovary syndrome: Is obesity a sine qua non? A clinical, hormonal, and metabolic assessment in relation to body mass index.

Saxena P, Prakash A, Nigam A, Mishra A.

Indian J Endocrinol Metab. 2012 Nov;16(6):996-9. doi: 10.4103/2230-8210.103011.

PMID:
23226650
[PubMed]
Free PMC Article
2.

[Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].

Li X, Lin JF.

Zhonghua Yi Xue Za Zhi. 2005 Dec 7;85(46):3266-71. Chinese.

PMID:
16409817
[PubMed - indexed for MEDLINE]
3.

[Exploration of the classification of polycystic ovarian syndrome].

Lin JF, Li X, Zhu MW.

Zhonghua Fu Chan Ke Za Zhi. 2006 Oct;41(10):684-8. Chinese.

PMID:
17199924
[PubMed - indexed for MEDLINE]
4.

Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.

Shi Y, Guo M, Yan J, Sun W, Zhang X, Geng L, Xu L, Chen Z.

Neuro Endocrinol Lett. 2007 Dec;28(6):807-10.

PMID:
18063948
[PubMed - indexed for MEDLINE]
5.

Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.

Holte J, Bergh T, Berne C, Lithell H.

Clin Endocrinol (Oxf). 1994 Oct;41(4):463-71.

PMID:
7955457
[PubMed - indexed for MEDLINE]
6.

The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.

Holte J, Bergh T, Gennarelli G, Wide L.

Clin Endocrinol (Oxf). 1994 Oct;41(4):473-81.

PMID:
7955458
[PubMed - indexed for MEDLINE]
7.

Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.

Pangaribuan B, Yusuf I, Mansyur M, Wijaya A.

Ther Adv Endocrinol Metab. 2011 Dec;2(6):235-45. doi: 10.1177/2042018811423770.

PMID:
23148188
[PubMed]
Free PMC Article
8.

Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.

Tan S, Hahn S, Benson S, Dietz T, Lahner H, Moeller LC, Schmidt M, Elsenbruch S, Kimmig R, Mann K, Janssen OE.

Eur J Endocrinol. 2007 Nov;157(5):669-76.

PMID:
17984248
[PubMed - indexed for MEDLINE]
Free Article
9.

Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome.

Fulghesu A, Magnini R, Portoghese E, Angioni S, Minerba L, Melis GB.

J Adolesc Health. 2010 May;46(5):474-81. doi: 10.1016/j.jadohealth.2009.10.008. Epub 2010 Jan 4.

PMID:
20413084
[PubMed - indexed for MEDLINE]
10.

Tissue insulin sensitivity and body weight in polycystic ovary syndrome.

Marsden PJ, Murdoch AP, Taylor R.

Clin Endocrinol (Oxf). 2001 Aug;55(2):191-9.

PMID:
11531925
[PubMed - indexed for MEDLINE]
11.

The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.

Yilmaz M, Biri A, Karakoç A, Törüner F, Bingöl B, Cakir N, Tiras B, Ayvaz G, Arslan M.

J Endocrinol Invest. 2005 Dec;28(11):1003-8.

PMID:
16483179
[PubMed - indexed for MEDLINE]
12.

Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.

Li L, Chen X, He Z, Zhao X, Huang L, Yang D.

J Pediatr Adolesc Gynecol. 2012 Dec;25(6):390-5. doi: 10.1016/j.jpag.2012.07.006. Epub 2012 Oct 22.

PMID:
23089573
[PubMed - indexed for MEDLINE]
13.

Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.

Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D.

Clin Endocrinol (Oxf). 2007 Jan;66(1):103-9.

PMID:
17201808
[PubMed - indexed for MEDLINE]
14.

Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters.

Chapman IM, Wittert GA, Norman RJ.

Clin Endocrinol (Oxf). 1997 Feb;46(2):175-81.

PMID:
9135699
[PubMed - indexed for MEDLINE]
15.
16.

Subcutaneous adipose tissue topography and metabolic disturbances in polycystic ovary syndrome.

Wehr E, Möller R, Horejsi R, Giuliani A, Kopera D, Schweighofer N, Groselj-Strele A, Pieber TR, Obermayer-Pietsch B.

Wien Klin Wochenschr. 2009;121(7-8):262-9. doi: 10.1007/s00508-009-1162-2.

PMID:
19562283
[PubMed - indexed for MEDLINE]
17.

In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls.

Economou F, Xyrafis X, Livadas S, Androulakis II, Argyrakopoulou G, Christakou CD, Kandaraki E, Palioura E, Diamanti-Kandarakis E.

Hormones (Athens). 2009 Jul-Sep;8(3):199-206.

PMID:
19671519
[PubMed - indexed for MEDLINE]
Free Article
18.

The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.

Pasquali R, Gambineri A, Anconetani B, Vicennati V, Colitta D, Caramelli E, Casimirri F, Morselli-Labate AM.

Clin Endocrinol (Oxf). 1999 Apr;50(4):517-27.

PMID:
10468913
[PubMed - indexed for MEDLINE]
19.

Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference?

Wijeyaratne CN, Balen AH, Barth JH, Belchetz PE.

Clin Endocrinol (Oxf). 2002 Sep;57(3):343-50.

PMID:
12201826
[PubMed - indexed for MEDLINE]
20.

Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.

Robinson S, Henderson AD, Gelding SV, Kiddy D, Niththyananthan R, Bush A, Richmond W, Johnston DG, Franks S.

Clin Endocrinol (Oxf). 1996 Mar;44(3):277-84.

PMID:
8729522
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk